Physician profile
David Shenker
NPI 1578511473
$27,632.79
in general payments reported to CMS, 2019-2025
29 companies · $31.00 in 2025
The $31.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2020: $222 · 2021: $852 · 2022: $11K · 2023: $14K · 2024: $133 · 2025: $31.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K · Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,636.25 |
| Food and Beverage | $463.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $23,928.36 | 2021-2023 | Nexplanon |
| Ethicon US, LLC | $944.32 | 2019-2025 | Enseal, Echelon; Endopath, Linx Reflux Management System |
| Abbvie INC. | $514.00 | 2019-2023 | Lo Loestrin Fe |
| Merz North America, INC. | $368.76 | 2022 | |
| Ethicon INC. | $340.00 | 2021 | |
| Pfizer INC. | $193.65 | 2021-2023 | |
| Therapeuticsmd, INC. | $146.75 | 2019-2022 | |
| Lupin INC. | $144.07 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.90 | 2019-2022 | |
| Intuitive Surgical, INC. | $121.20 | 2019 | |
| Myovant Sciences INC. | $117.44 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $78.29 | 2021-2022 | |
| Duchesnay USA Incorporated | $75.66 | 2019 | |
| Exeltis, USA INC. | $62.66 | 2020-2022 | |
| Evofem Biosciences, INC. | $57.84 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $56.03 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $53.85 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $44.30 | 2019-2021 | |
| Avion Pharmaceuticals | $44.23 | 2019-2020 | |
| Coloplast Corp | $41.36 | 2020-2023 | Altis |
| Agile Therapeutics, INC. | $31.01 | 2021 | |
| Minerva Surgical, INC | $26.19 | 2019-2023 | |
| Becton, Dickinson and Company | $20.59 | 2019 | |
| Astellas Pharma US INC | $19.57 | 2020 | |
| Amag Pharmaceuticals, INC. | $19.16 | 2020 | |
| Allergan, INC. | $17.93 | 2022 | |
| Radius Health, INC. | $16.19 | 2020 | |
| Merck Sharp & Dohme LLC | $13.42 | 2020 | |
| Sage Therapeutics, LLC | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shenker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.